The ECMC Paediatric Network brings together clinicians and translational scientists to run early phase clinical trials for children and young people with cancer. Formed of 12 paediatric phase I/II centres, the network functions as a single virtual centre to improve patient recruitment and expand geographical access to novel anticancer agents.
- 5 Innovative Therapies for Children with Cancer European Consortium (ITCC) designated first-in-child centres
- A dedicated patient referral network
- Whole-genome and targeted panel sequencing
- Advanced imaging and biobanking
If you would like to learn more, please get in touch with Lamise Nasr, our Paediatric Network Manager: email@example.com